Topical probiotic Lactobacillus lactis treatment in atopic dermatitis: a placebo-controlled pilot study on tolerability and efficacy.
- 2026-02-03
- Clinical Trial · n = 13
- Frontiers in medicine 13
- Ville Salo
- Anita Remitz
- Antti Lauerma
- Alexander Salava
- PubMed: 41709889
- DOI: 10.3389/fmed.2026.1694229
- Moderate evidence
- Clinical
sleep disturbance VAS, p = 1.00, CI: 0.79-1.00
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 3%, 10%, and 30% cream (probiotic lysate cream)